Earum Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
For the nine months, sales was INR 125.6 million compared to INR 162.97 million a year ago. Revenue was INR 148.22 million compared to INR 185.8 million a year ago. Net income was INR 17.69 million compared to INR 29.4 million a year ago. Basic earnings per share from continuing operations was INR 0.29 compared to INR 0.48 a year ago. Diluted earnings per share from continuing operations was INR 0.29 compared to INR 0.48 a year ago.